1. Home
  2. NVCR vs PYCR Comparison

NVCR vs PYCR Comparison

Compare NVCR & PYCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PYCR
  • Stock Information
  • Founded
  • NVCR 2000
  • PYCR 1990
  • Country
  • NVCR Jersey
  • PYCR United States
  • Employees
  • NVCR N/A
  • PYCR N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PYCR Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • PYCR Technology
  • Exchange
  • NVCR Nasdaq
  • PYCR Nasdaq
  • Market Cap
  • NVCR 3.0B
  • PYCR 3.2B
  • IPO Year
  • NVCR 2015
  • PYCR 2021
  • Fundamental
  • Price
  • NVCR $30.97
  • PYCR $19.18
  • Analyst Decision
  • NVCR Buy
  • PYCR Buy
  • Analyst Count
  • NVCR 5
  • PYCR 16
  • Target Price
  • NVCR $33.40
  • PYCR $20.56
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • PYCR 943.3K
  • Earning Date
  • NVCR 10-30-2024
  • PYCR 02-05-2025
  • Dividend Yield
  • NVCR N/A
  • PYCR N/A
  • EPS Growth
  • NVCR N/A
  • PYCR N/A
  • EPS
  • NVCR N/A
  • PYCR N/A
  • Revenue
  • NVCR $577,738,000.00
  • PYCR $678,836,000.00
  • Revenue This Year
  • NVCR $19.13
  • PYCR $13.78
  • Revenue Next Year
  • NVCR $5.38
  • PYCR $11.29
  • P/E Ratio
  • NVCR N/A
  • PYCR N/A
  • Revenue Growth
  • NVCR 14.63
  • PYCR 17.45
  • 52 Week Low
  • NVCR $11.70
  • PYCR $10.92
  • 52 Week High
  • NVCR $34.13
  • PYCR $22.14
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.66
  • PYCR 55.38
  • Support Level
  • NVCR $29.85
  • PYCR $18.85
  • Resistance Level
  • NVCR $34.13
  • PYCR $20.49
  • Average True Range (ATR)
  • NVCR 2.00
  • PYCR 0.64
  • MACD
  • NVCR -0.33
  • PYCR -0.20
  • Stochastic Oscillator
  • NVCR 44.92
  • PYCR 17.75

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PYCR Paycor HCM Inc.

Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.

Share on Social Networks: